comparemela.com

Rakesh Jain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Non-Life Policies: Comparing non-life policies, claim process to get easier | Mumbai News

Insurance regulator Irdai introduces reforms in non-life insurance, including 'base product' requirement for insurers to enhance transparency. Policyholders can now cancel policies without reason, with stricter claim settlement timelines enforced. Learn more about the improvements in non-life insurance policies.

Why Clinicians Should Be Excited About Austedo XR

Rakesh Jain, MD, shares more about the recent approval of Austedo XR for the treatment of tardive dyskinesia and Huntington disease chorea control.

FDA Approves Deutetrabenazine Once-Daily Extended-Release Tablets to Treat TD and HD Chorea

FDA Approves Deutetrabenazine Once-Daily Extended-Release Tablets to Treat TD and HD Chorea
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

FDA Approves Deutetrabenazine Once Pill Extended-Release Tablets to Treat TD and HD Chorea

FDA Approves Deutetrabenazine Once Pill Extended-Release Tablets to Treat TD and HD Chorea
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia and Huntington Disease

Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia and Huntington Disease
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.